Bcrx stocktwits
BioCryst Pharmaceuticals, Inc. (BCRX) stock price, quote ... BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted five newly-hired employees inducement options to purchase an aggregate of 147,500 shares of BioCryst common stock on May 29, 2020 as inducements material to each employee entering into BioCryst Pharmaceuticals Inc (BCRX) Stock Analysis ... Find out if BCRX is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on BCRX. BCRX - Stock quote for BIOCRYST PHARMACEUTICALS, INC ... View the latest BCRX stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of BIOCRYST PHARMACEUTICALS, INC.. BioCryst Pharmaceuticals Shares Outstanding | BCRX
#BCRX. Filter by: Real-Time. Do Not Sell My Personal Information. When you visit our website, we store cookies on your browser to collect information.
BCRX -- Is Its Stock Price A Worthy Investment? Learn More. BCRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.55% of US stocks. Revenue growth over the past 12 months for Biocryst Pharmaceuticals Inc comes in at 111.71%, a number that bests 95.05% of the US stocks we're tracking.
BCRX Stock Analysis: Price, Forecast, and News
Currently (8:22), BCRX is trading at $4.05 per share after a loss of $3.34 per share or 45.20% thus far today. Stop wasting your time! Start finding winning trades in minutes with Trade Ideas !
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings Report ...
BCRX employees now have every incentive to keep BCRX stock price $4.50 and beyond. BCRX is a company in the growth phase that requires investors' patience to see it to fruition. Day traders make a few dollars zipping in and out, but I believe longs that truly believe in BCRX business fundamentals will make out with the most at the end. BioCryst Pharmaceuticals, Inc. (BCRX) Latest News - STCK.PRO Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits. Company Profile. June 01, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today the completion of an underwritten public offering of 22,044,447 shares of its common stock, including NASDAQ:BCRX BioCryst Pharmaceuticals Price Target ... May 03, 2020 BioCryst Pharmaceuticals Inc (BCRX) Quote | Morningstar
BioCryst Pharmaceuticals Shares Outstanding | BCRX
BCRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 0.55% of US stocks. Revenue growth over the past 12 months for Biocryst Pharmaceuticals Inc comes in at 111.71%, a number that bests 95.05% of the US stocks we're tracking.